NASDAQ : CNTG

Centogene N.V.

$0.325 USD

$0.33 (0%)

Volume
7.23M
Average Volume
431.57K
Market Capitalization
$9.42M
P/E Ratio
-0.22
Dividend Yield
0.00%
Price Target
$2.50
Year High
$0.43
Year Low
$0.33
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.02
Company Overview

NASDAQ

Kim Stratton

Medical - Diagnostics & Research

Healthcare

CNTG

384

DE

USD

https://www.centogene.com

49 381 80113 500

N1976T109

0001757097

Liquidity Metrics

-3.18

1.02

0.96

0.42

0.00

Sales & Valuation

$48.54M

0.17

-0.31

-0.24

-1.21

Profitability

-$1.26

-$35.53M

-73.21%

-72.62%

397.65%

-46.05%

P/E Metrics

-0.22

-0.01

-0.01

Analyst Price Target & Rating

$2.50

$2.50

$2.50

N/A

0/5

7 Analysts

-87.00%

Financial Health Scores

-4.03

2/9

$653K

$77.16M

$102.44M

-$35.79M

Key Metrics (TTM)

$70.39M

1.45

-3.62

1.02

397.65%

-47.95%

-447.96%

-416.88%

109 days

Company Executives
Name Title
Andrin Oswald Advisor
Peter Bauer Interim MD, Chief Medical & Genomic Officer and Member of Management Board
Ian Rentsch Chief Commercial Officer & GM of Pharma
Jose Miguel Coego Rios Chief Financial Officer, Legal & IT and Member of Management Board
Kim Stratton Chief Executive Officer & Member of Management Board
Poll Results

No votes yet today — be the first to share your view!

About Centogene N.V. (NASDAQ:CNTG) Stock

Centogene N.V., along with its affiliates, operates globally with a primary focus on rare diseases. The company excels at converting diverse real-world data—spanning clinical, genetic, and other sources—into practical insights for patients, medical professionals, and pharmaceutical enterprises worldwide. Its activities are organized across three core divisions: Pharmaceutical, Diagnostics, and COVID-19 testing. At the heart of Centogene's strategy is its unique rare disease platform, a comprehensive repository of biological samples and integrated data. This platform consolidates epidemiological, phenotypic, and heterogenetic information, significantly improving the identification and ongoing surveillance of rare hereditary conditions. Furthermore, it plays a crucial role in accelerating th ... e development of orphan drugs. The company provides an array of services within its Pharmaceutical segment, including target identification, early patient recruitment, epidemiological intelligence, biomarker discovery, and patient monitoring. Its Diagnostics arm offers genetic sequencing and diagnostic testing, reaching physicians, laboratories, and hospitals directly or through established distribution channels. Centogene also supplies COVID-19 testing solutions, covering both PCR and antigen tests. Established in 2006 and based in Rostock, Germany, Centogene N.V. holds key collaborative and licensing agreements with prominent partners such as Shire International GmbH, Pfizer Inc., Dr. Bauer Laboratoriums GmbH, Fraport AG, Takeda Pharmaceutical Company Limited, and Twist Bioscience Corporation.

Frequently Asked Questions

What is the current Centogene N.V. (CNTG) stock price?

Centogene N.V.(NASDAQ:CNTG) stock price is $0.325 in the last trading session. During the trading session, CNTG stock reached the peak price of $0.429 while $0.325 was the lowest point it dropped to. The percentage change in CNTG stock occurred in the recent session was 0% while the dollar amount for the price change in CNTG stock was $0.33.

CNTG's industry and sector of operation?

The NASDAQ listed CNTG is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of CNTG?

Andrin Oswald | Advisor
Peter Bauer | Interim MD, Chief Medical & Genomic Officer and Member of Management Board
Ian Rentsch | Chief Commercial Officer & GM of Pharma
Jose Miguel Coego Rios | Chief Financial Officer, Legal & IT and Member of Management Board
Kim Stratton | Chief Executive Officer & Member of Management Board

How many employees does CNTG have?

Number of CNTG employees currently stands at 384. CNTG operates from Am Strande 7, Rostock, None 18055, DE.

Link for CNTG official website?

Official Website of CNTG is: https://www.centogene.com

How do I contact CNTG?

CNTG could be contacted at phone #49 381 80113 500 and can also be accessed through its website. CNTG operates from Am Strande 7, Rostock, None 18055, DE.

How many shares of CNTG are traded daily?

The average number of CNTG shares traded daily for last 3 months was 431.57K.

What is the market cap of CNTG currently?

The market value of CNTG currently stands at $9.42M with its latest stock price at $0.325